Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer ; volume:23 ; number:1 ; day:1 ; month:5 ; year:2023 ; pages:1-10 ; date:12.2023
BMC cancer ; 23, Heft 1 (1.5.2023), 1-10, 12.2023
- Urheber
-
Park, Se Jun
Park, Ju Yeon
Shin, Kabsoo
Hong, Tae Ho
Lee, MyungAh
Kim, Younghoon
Kim, In-Ho
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10811-8
- URN
-
urn:nbn:de:101:1-2023090511044757347445
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Park, Se Jun
- Park, Ju Yeon
- Shin, Kabsoo
- Hong, Tae Ho
- Lee, MyungAh
- Kim, Younghoon
- Kim, In-Ho
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
The role of exosomal PD-L1 in tumor progression and immunotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
The role of exosomal PD-L1 in tumor progression and immunotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
The role of exosomal PD-L1 in tumor progression and immunotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)